Mutations in the ERS1 gene which codes ER occur in 20–40% of metastatic ER-positive luminal breast cancer and less often in early forms (1–2%) and can be detected via NGS sequencing [43, 49, 56, 57]. This evidence concerns the gene ESR1 and breast carcinoma.